Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine.

Folegatti PM, Bellamy D, Roberts R, Powlson J, Edwards NJ, Mair CF, Bowyer G, Poulton I, Mitton CH, Green N, Berrie E, Lawrie AM, Hill AVS, Ewer KJ, Hermon-Taylor J, Gilbert SC.

Vaccines (Basel). 2019 May 15;7(2). pii: E40. doi: 10.3390/vaccines7020040.

2.

The Consensus from the Mycobacterium avium ssp. paratuberculosis (MAP) Conference 2017.

Kuenstner JT, Naser S, Chamberlin W, Borody T, Graham DY, McNees A, Hermon-Taylor J, Hermon-Taylor A, Dow CT, Thayer W, Biesecker J, Collins MT, Sechi LA, Singh SV, Zhang P, Shafran I, Weg S, Telega G, Rothstein R, Oken H, Schimpff S, Bach H, Bull T, Grant I, Ellingson J, Dahmen H, Lipton J, Gupta S, Chaubey K, Singh M, Agarwal P, Kumar A, Misri J, Sohal J, Dhama K, Hemati Z, Davis W, Hier M, Aitken J, Pierce E, Parrish N, Goldberg N, Kali M, Bendre S, Agrawal G, Baldassano R, Linn P, Sweeney RW, Fecteau M, Hofstaedter C, Potula R, Timofeeva O, Geier S, John K, Zayanni N, Malaty HM, Kahlenborn C, Kravitz A, Bulfon A, Daskalopoulos G, Mitchell H, Neilan B, Timms V, Cossu D, Mameli G, Angermeier P, Jelic T, Goethe R, Juste RA, Kuenstner L.

Front Public Health. 2017 Sep 27;5:208. doi: 10.3389/fpubh.2017.00208. eCollection 2017.

3.

Lamina propria macrophage phenotypes in relation to Escherichia coli in Crohn's disease.

Elliott TR, Rayment NB, Hudspith BN, Hands RE, Taylor K, Parkes GC, Prescott NJ, Petrovska L, Hermon-Taylor J, Brostoff J, Boussioutas A, Mathew CG, Bustin SA, Sanderson JD.

BMC Gastroenterol. 2015 Jul 3;15:75. doi: 10.1186/s12876-015-0305-3.

4.

Defective macrophage handling of Escherichia coli in Crohn's disease.

Elliott TR, Hudspith BN, Rayment NB, Prescott NJ, Petrovska L, Hermon-Taylor J, Brostoff J, Boussioutas A, Mathew CG, Sanderson JD.

J Gastroenterol Hepatol. 2015 Aug;30(8):1265-74. doi: 10.1111/jgh.12955.

PMID:
25809337
5.

Mycobacterium avium Subspecies paratuberculosis: Human Exposure through Environmental and Domestic Aerosols.

Rhodes G, Richardson H, Hermon-Taylor J, Weightman A, Higham A, Pickup R.

Pathogens. 2014 Jul 16;3(3):577-95. doi: 10.3390/pathogens3030577.

6.

A rhodanine agent active against non-replicating intracellular Mycobacterium avium subspecies paratuberculosis.

Bull TJ, Linedale R, Hinds J, Hermon-Taylor J.

Gut Pathog. 2009 Dec 23;1:25. doi: 10.1186/1757-4749-1-25.

7.

Mycobacterium avium subspecies paratuberculosis, Crohn's disease and the Doomsday scenario.

Hermon-Taylor J.

Gut Pathog. 2009 Jul 14;1(1):15. doi: 10.1186/1757-4749-1-15.

8.

Gut pathogens: invaders and turncoats in a complex cosmos.

Hermon-Taylor J.

Gut Pathog. 2009 Feb 3;1(1):3. doi: 10.1186/1757-4749-1-3.

9.

A novel multi-antigen virally vectored vaccine against Mycobacterium avium subspecies paratuberculosis.

Bull TJ, Gilbert SC, Sridhar S, Linedale R, Dierkes N, Sidi-Boumedine K, Hermon-Taylor J.

PLoS One. 2007 Nov 28;2(11):e1229.

10.

Mycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn's disease and Johne's disease: common neural and immune pathogenicities.

Scanu AM, Bull TJ, Cannas S, Sanderson JD, Sechi LA, Dettori G, Zanetti S, Hermon-Taylor J.

J Clin Microbiol. 2007 Dec;45(12):3883-90. Epub 2007 Oct 3.

12.

Replication and long-term persistence of bovine and human strains of Mycobacterium avium subsp. paratuberculosis within Acanthamoeba polyphaga.

Mura M, Bull TJ, Evans H, Sidi-Boumedine K, McMinn L, Rhodes G, Pickup R, Hermon-Taylor J.

Appl Environ Microbiol. 2006 Jan;72(1):854-9.

13.
14.

Mycobacterial interspersed repetitive units (MIRU) differentiate Mycobacterium avium subspecies paratuberculosis from other species of the Mycobacterium avium complex.

Bull TJ, Sidi-Boumedine K, McMinn EJ, Stevenson K, Pickup R, Hermon-Taylor J.

Mol Cell Probes. 2003 Aug;17(4):157-64.

PMID:
12944117
15.

Monitoring bacterial pathogens in the environment: advantages of a multilayered approach.

Pickup RW, Rhodes G, Hermon-Taylor J.

Curr Opin Biotechnol. 2003 Jun;14(3):319-25. Review.

PMID:
12849786
16.

Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease.

Bull TJ, McMinn EJ, Sidi-Boumedine K, Skull A, Durkin D, Neild P, Rhodes G, Pickup R, Hermon-Taylor J.

J Clin Microbiol. 2003 Jul;41(7):2915-23.

17.

Use of bioinformatics to predict a function for the GS element in Mycobacterium avium subspecies paratuberculosis.

Sheridan J, Bull T, Hermon-Taylor J.

J Mol Microbiol Biotechnol. 2003;5(1):57-66.

PMID:
12673062
19.

Mycobacterium avium subspecies paratuberculosis in the causation of Crohn's disease.

Hermon-Taylor J.

World J Gastroenterol. 2000 Oct;6(5):630-632. No abstract available.

20.

Crohn's disease caused by Mycobacterium avium subspecies paratuberculosis: a public health tragedy whose resolution is long overdue.

Hermon-Taylor J, Bull T.

J Med Microbiol. 2002 Jan;51(1):3-6. No abstract available.

PMID:
11800469
21.

Protagonist. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease.

Hermon-Taylor J.

Gut. 2001 Dec;49(6):755-6. No abstract available.

23.

Characterization of IS900 loci in mycobacterium avium subsp. paratuberculosis and development of multiplex PCR typing

Bull TJ, Hermon-Taylor J, Pavlik I I, El-Zaatari F, Tizard M.

Microbiology. 2000 Dec;146 (Pt 12):3285. No abstract available.

PMID:
11101687
24.

Characterization of IS900 loci in Mycobacterium avium subsp. paratuberculosis and development of multiplex PCR typing.

Bull TJ, Hermon-Taylor J, Pavlik I, El-Zaatari F, Tizard M.

Microbiology. 2000 Sep;146 ( Pt 9):2185-2197. doi: 10.1099/00221287-146-9-2185. Erratum in: Microbiology 2000 Dec;146(Pt 12):3285.

PMID:
10974106
25.

Causation of Crohn's disease by Mycobacterium avium subspecies paratuberculosis.

Hermon-Taylor J, Bull TJ, Sheridan JM, Cheng J, Stellakis ML, Sumar N.

Can J Gastroenterol. 2000 Jun;14(6):521-39. Review.

PMID:
10888733
26.

Cerebral trypsinogen expression in human and rat cerebrospinal fluid.

Critchley G, Sumar N, O'Neill K, Hermon-Taylor J, Bell BA.

Neurosci Lett. 2000 Mar 31;283(1):13-6.

PMID:
10729622
27.

Hyperenterostatinemia in premenopausal obese women.

Prasad C, Imamura M, Debata C, Svec F, Sumar N, Hermon-Taylor J.

J Clin Endocrinol Metab. 1999 Mar;84(3):937-41.

PMID:
10084574
28.

The causation of Crohn's disease and treatment with antimicrobial drugs.

Hermon-Taylor J.

Ital J Gastroenterol Hepatol. 1998 Dec;30(6):607-10. No abstract available.

PMID:
10076782
29.

A low G+C content genetic island in Mycobacterium avium subsp. paratuberculosis and M. avium subsp. silvaticum with homologous genes in Mycobacterium tuberculosis.

Tizard M, Bull T, Millar D, Doran T, Martin H, Sumar N, Ford J, Hermon-Taylor J.

Microbiology. 1998 Dec;144 ( Pt 12):3413-23.

PMID:
9884234
30.

Distribution and characterization of enterostatin-like immunoreactivity in human cerebrospinal fluid.

Imamura M, Sumar N, Hermon-Taylor J, Robertson HJ, Prasad C.

Peptides. 1998;19(8):1385-91.

PMID:
9809653
31.

Mycobacterium paratuberculosis cervical lymphadenitis, followed five years later by terminal ileitis similar to Crohn's disease.

Hermon-Taylor J, Barnes N, Clarke C, Finlayson C.

BMJ. 1998 Feb 7;316(7129):449-53. Review. No abstract available.

32.

Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis.

Tenner S, Fernandez-del Castillo C, Warshaw A, Steinberg W, Hermon-Taylor J, Valenzuela JE, Hariri M, Hughes M, Banks PA.

Int J Pancreatol. 1997 Apr;21(2):105-10.

PMID:
9209951
33.

Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics.

Gui GP, Thomas PR, Tizard ML, Lake J, Sanderson JD, Hermon-Taylor J.

J Antimicrob Chemother. 1997 Mar;39(3):393-400.

PMID:
9096189
34.

IS900 targets translation initiation signals in Mycobacterium avium subsp. paratuberculosis to facilitate expression of its hed gene.

Doran T, Tizard M, Millar D, Ford J, Sumar N, Loughlin M, Hermon-Taylor J.

Microbiology. 1997 Feb;143 ( Pt 2):547-52.

PMID:
9043131
35.

IS900 PCR to detect Mycobacterium paratuberculosis in retail supplies of whole pasteurized cows' milk in England and Wales.

Millar D, Ford J, Sanderson J, Withey S, Tizard M, Doran T, Hermon-Taylor J.

Appl Environ Microbiol. 1996 Sep;62(9):3446-52.

36.

Activation of human granulocyte type 1-prophospholipase A2.

Rae D, Beechey-Newman N, Burditt L, Sumar N, Hermon-Taylor J.

Scand J Gastroenterol Suppl. 1996;219:24-7. Review.

PMID:
8865467
37.

Cholecystokinin-8 induces edematous pancreatitis in dogs associated with short burst of trypsinogen activation.

Simpson KW, Beechey-Newman N, Lamb CR, Smyth JB, Hughes G, Coombe K, Sumar N, Hermon-Taylor J.

Dig Dis Sci. 1995 Oct;40(10):2152-61.

PMID:
7587782
39.

Measles virus and Crohn's disease.

Hermon-Taylor J, Ford J, Sumar N, Millar D, Doran T, Tizard M.

Lancet. 1995 Apr 8;345(8954):922-3. No abstract available.

PMID:
7707825
40.

Type 1-prophospholipase A2 propeptide immunoreactivity is released from activated granulocytes.

Rae D, Sumar N, Beechey-Newman N, Gudgeon M, Hermon-Taylor J.

Clin Biochem. 1995 Feb;28(1):71-8.

PMID:
7720230
41.

Type 1 prophospholipase A2 propeptide in acute lung injury.

Rae D, Porter J, Beechey-Newman N, Sumar N, Bennett D, Hermon-Taylor J.

Lancet. 1994 Nov 26;344(8935):1472-3.

PMID:
7968121
42.

A pilot study of intraperitoneal cisplatin in the management of gastric cancer.

Jones AL, Trott P, Cunningham D, Rosin RD, Coleman D, Sauven P, Glazer G, Cunningham D, Hermon-Taylor J, Coombes RC, et al.

Ann Oncol. 1994 Feb;5(2):123-6.

43.
44.

The thermal resistance of Mycobacterium paratuberculosis in raw milk under conditions simulating pasteurization.

Chiodini RJ, Hermon-Taylor J.

J Vet Diagn Invest. 1993 Oct;5(4):629-31. No abstract available.

PMID:
8286469
45.

Suppression of anchorage-independent growth after gene transfection.

Winterbourne DJ, Thomas S, Hermon-Taylor J.

Br J Cancer. 1993 Aug;68(2):251-8.

46.

Assay of trypsinogen activation in the cat experimental model of acute pancreatitis.

Karanjia ND, Widdison AL, Jehanli A, Hermon-Taylor J, Reber HA.

Pancreas. 1993 Mar;8(2):189-95.

PMID:
8460094
47.

Causation of Crohn's disease: the impact of clusters.

Hermon-Taylor J.

Gastroenterology. 1993 Feb;104(2):643-6. No abstract available.

PMID:
8425709
48.
49.

p43, the protein product of the atypical insertion sequence IS900, is expressed in Mycobacterium paratuberculosis.

Tizard ML, Moss MT, Sanderson JD, Austen BM, Hermon-Taylor J.

J Gen Microbiol. 1992 Aug;138 Pt 8:1729-36.

PMID:
1326596
50.

Mycobacterial aetiology of sarcoidosis.

Graham DY, Markesich DC, Kalter DC, Moss MT, Hermon-Taylor J, el-Zaatari FA.

Lancet. 1992 Jul 4;340(8810):52-3. No abstract available.

PMID:
1351626

Supplemental Content

Loading ...
Support Center